Choroidal Neovascularization Secondary to Pathologic Myopia
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization Secondary to Pathologic Myopia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Faricimab for choroidal neovascularization due to pathologic myopia has compl…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]
Phase 3 trial evaluating faricimab for choroidal neovascularization due to pathologic myopia has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. [Phase 3]
Phase 3 study evaluating criteria for re-treatment with ranibizumab in patients with visual impairment from choroidal neovascularization sec…